“…Some of such areas are: CT images, growth factor levels in incident breast cancer, hormone receptor status, cytokine circulation, secretagogue users in breast cancer treatments, chemokine levels, breast cancer and diabetes mellitus co-infection and treatment, breast cancer and HIV treatment, breast cancer and pregnancy. Others are: proteome analysis, risk factors analysis, breast examination, screening, management and breast cancer awareness, epidemiology, risk assessment tools, treatment options: radiotherapy treatment versus chemotherapy, survival analysis, breast cancer subtypes, biomarkers, socio-cultural barriers to treatment, socio-demographic factors and alternative medicine approach, genetic risk, dietary patterns, early diagnostics and treatment and others [1] , [2] , [3] , [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] .…”